Smart health for a better life
Capital increase: warrants at €120/share.
If you want to invest in Beo Santé :
Objective: to accelerate marketing and develop new versions of the VATA application co-developed with the founders Physio R&D.
Strong collaboration between experts in new technologies and medical researchers
An experienced team for over 10 years
A consolidated partnership since 2016
Ongoing clinical trials
Market penetration through sales to laboratories
Find out more